Fibromyalgia and Migraine, Two Faces of the Same Mechanism: Serotonin as the Common Clue for Pathogenesis and Therapy

Advances in Experimental Medicine and Biology

Volumn 398, Issue , 1996, Pages 373-379

  Nicolodi, M ^a   Sicuteri, F ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYTRYPTOPHAN; AMITRIPTYLINE; MONOAMINE OXIDASE INHIBITOR; PARGYLINE; PHENELZINE; SEROTONIN; TRICYCLIC ANTIDEPRESSANT AGENT;

ANXIETY; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; FEMALE; FIBROMYALGIA; HUMAN; MALE; MIGRAINE; NEUROPSYCHOLOGICAL TEST; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL;

5-HYDROXYTRYPTOPHAN; AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANXIETY; DRUG THERAPY, COMBINATION; FEMALE; FIBROMYALGIA; HUMANS; MALE; MIGRAINE DISORDERS; MONOAMINE OXIDASE INHIBITORS; NEUROPSYCHOLOGICAL TESTS; PAIN MEASUREMENT; PARGYLINE; PHENELZINE; QUESTIONNAIRES; SEROTONIN;

EID: 0030347307     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4613-0381-7_58     Document Type: Article

References (35)

1. Bastos, S.B., de Almeida-Filho, N., Santana, V.S., 1993, Prevalence of headache as a symptom in an urban area of Salvador, Bahia. Arq Neuropsiquiatr, 51 (3): 307
2. Boulton, A.A., Juorrio, A.V., Peterson, I.A., 1990, Phenylethylamine in the CNS: effects ofmonoamine oxidase inhibiting drugs, deuterium substitution and lesions and its role in the neuromodulation of catecholaminergic neurotransmission. J Neural Trans 29: 119
3. Creese, I., Sibley, D.R., 1981, Receptor adaptations to centrally acting drugs. Ann Rev Pharmacol Toxicol 21: 357
4. Cremata, V.Y., Koe, B.K., 1966, Clinical pharmacological evaluation of p-chlorophenylalanine: a new serotonin-depleting agent. Clin Pharmacol Ther 7: 768
5. Curzon, G., 1979, Relationship between plasma, CSF and brain tryptophan. J Neural Transm 15:81
6. De Montis, M.G., Olianas, M,C,. Mulas, G., Tagliamonte, A., 1977, Evidence that only free serum tryptophan exchanges with the brain. Phar Res Commun 9 (2): 215
7. Foster, A.C., Vezzani, A.M., French, E.D., Schwarcz, R., 1984, Kynurenic acid blocks neurotoxicity and seizures in rats by the related brain metabolite quinolinic acid. Neurosci Lett 48:273
8. Handworker, H.O., 1993, Mechanisms of cutaneous and subcutaneous hyperalgesia, in "New Trends in Referred Pain and Hyperalgesia", Vecchiet L, Albe-Fessard D, Lindblom U, eds, Elsevier, Amsterdam (1993)
9. Heinonen, E.H., Lammintausta, R.A., 1991, A review of the pharmacology of selegiline. Acta Neurol Scand 84 (136): 44
10. International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988, 8 (7)
11. King, R., 1980, Pain and tryptophan. J Neurosurg 53: 44
12. Koshikawa, F., Koshikawa, N., Stephenson, J.D., 1985, Effects of antidepressant drugs and cortical 5-HT2 receptors and wet-dog shakes in rats. Eur J Pharmacol 118: 273
13. Lance, J.W., 1992, Possible role of serotonin in the migraine syndrome, in: "Advances in Pain Research and Therapy", Sicuteri F., Terenius L., Vecchiet L., Maggi CA. ,eds, Raven Press, New York
14. Mc Cain, G.A., 1990, Management of fibromyalgia syndrome. In: JR Fricton, A Essam (eds). Advances in Pain Research and Therapy, Vol 17, Raven Press, New York
15. Moroni, F., Lombardi, G., Carlà, V., Moneti G., 1984, The excitotoxin quinolinic acid is present and unevenly distributed in the rat brain. Brain Res 295:352
16. Munoz, M., Dumas, M., Boutros-Toni, F., Coquelle, D., Nicolas, A., Ndzanga, E., Boa, F., Vallat, J.M., Dartigues, J.F., 1993. Prevalence of headache in a representative sample of the population in a French department (Haute-Vienne-Limousin) Headache 33 (10) 521
17. Nicolodi, M., Sicuteri, F., 1992, Central panalgia as an expression of systemic analgodeficiency. in: "Advances in Pain Research and Therapy", F. Sicuteri, L Terenius, L Vecchiet, CA Maggi, eds, Raven Press, New York
18. Panagiotidis, G., Stenstrom, A., Lundquist, I., 1993, Effects of adrenergic and cholinergic stimulation on islet monoamine oxidase activity and insulin secretion in the mouse. Eur J Pharmacol 233 (3): 285
19. Perkins, M.N., Stone, T.W., 1982, An iontophoretic investigation of the actions of convulsant kynurenines and the interaction with endogenous excitant quinolinic acid. Brain Res 247: 184
20. Rajiv, J., Welch, K.M.A., D'Andrea, G., 1989, Serotonergic hypofunction in migraine: a synthesis of evidence based on platelet dense body dysfunction. Cephalalgia 9: 18
21. Seltzer, S., 1985, Pain relief by dietary manipulations and tryptophan supplements. J Endodontics 11(10): 449
22. Sicuteri, F., 1971, Pain syndrome in man following treatment with p-chlorophenylalanine. Pharmacol Res Comm 3(4): 401
23. Sicuteri, F., 1975, 5-hydroxytryptophan in the prophylaxis of migraine. Pharmacol Res Commun 4(3): 213
24. Sicuteri, F., Michelacci, S,. Franchi, G., 1962, Contributo alla caratterizzazione della farmacologia della reserpina sul sistema nervoso centrale. antagonismo di un bloccante adrenergico sul fenomeno dell'eccitazione paradossa da reserpina nel topo. Boll Soc Ital Biol Sper 38 (8): 381
25. Sicuteri, F., Fanciullacci, M., Del Bianco, P.L., 1965, Variata reattività alla 5-idrossitriptamina ed alla nor-adrenalina da anti monoamino ossidasici nell' uomo. Boll Soc Ital Biol Sper 41 (9): 467
26. Sicuteri, F., Anselmi, B., Del Bianco, P.L., 1973, 5-hydroxytryptamine supersenstivity as a new theory of headache and central pain: a clinical pharmacological approach with p-chlorophenylalanine. Psychopharmacology 29: 347
27. Sicuteri, F., Anselmi, B., Fanciullacci, M., 1974, The serotonin (5-HT) theory of migraine. Adv Neurol 4: 383
28. Sicuteri, F., Anselmi, B., Del Bianco, P.L., 1978, Systemic non organic central pain with decentralization super-sensitivity. Headache 18: 133
29. Sicuteri, F., Nicolodi, M., Fusco, B.M., 1984, Abnormal sensitivity to agonists, antagonists and releasers. in: "Basic Mechanism of headache", J Olesen, L Edvinnsson,eds, Elsevier, Amsterdam
30. Sicuteri, F., Nicolodi, M., 1991, Serotonin: a "Sphynx" in migraine. in, "Headache and depression: serotonin pathways as a common clue", Nappi G et al., eds, Raven Press, New York
31. Simons, D., 1990, Muscular pain syndromes, in: "Advances in Pain Research and Therapy", JR Fricton, A Essam ,eds, Raven Press, New York
32. Wang, R.I.H., Wiesen, R.L., Treul, S., Stockdale, S., 1976, Brief anxiety rating test. J Clin Pharmacol 16 (2/3): 99-105
33. Wolfe, F., Smythe, H.A., Yunus, M.B., 1990, The american college of rheumatology 1990 Criteria for the classification of fibromyalgia, report of the multicenter criteria committee. Arthritis Rheum 33: 160
34. Zimmermann, M., 1991, Pathophysiological mechanisms of fibromyalgia. Clin J Pain 7(1): 8
35. Zung, WW. 1965 A self rating depression scale. Arch Gen Psychiatry 12: 163-65.